CYRX241115C5000
- 0.00
- 0.000.00%
Cryoport Newsroom
Earnings Preview: Cryoport to Report Financial Results Post-market on November 07
CryoPort, Inc. (CYRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Morgan Stanley Maintains Cryoport(CYRX.US) With Hold Rating, Cuts Target Price to $8
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
Cryoport And Gulf Coast Regional Blood Center Announce A Strategic Alliance To Enhance The Availability Of High-Quality, Manufacture-Ready Cryopreserved Allogeneic Leukopaks For Cellular Therapy Research, Development, And Treatment.
Express News | Tmrw Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
Peeling Back The Layers: Exploring CryoPort Through Analyst Insights
Cryoport Is Maintained at Neutral by UBS
CryoPort Analyst Ratings
UBS Initiates Cryoport(CYRX.US) With Hold Rating, Announces Target Price $9
Cryoport Price Target Raised to $9 From $7 at UBS
Cryoport Selected by VGXI for Biostorage, Bioservices and Supply Chain Solutions
Leerink Partners Maintains Cryoport(CYRX.US) With Hold Rating
CryoPort (CYRX) Gets a Hold From Leerink Partners
A Piece Of The Puzzle Missing From Cryoport, Inc.'s (NASDAQ:CYRX) Share Price
Express News | Cryoport Launches IntegriCell Cryopreservation Solution; Open Facility At Houston Campus
Should You Hold Cryoport (CYRX)?
Cryoport (NASDAQ:CYRX) Shareholders Are up 15% This Past Week, but Still in the Red Over the Last Three Years
CryoPort's Revised Guidance and Volatility Outlook Prompt Hold Rating
Express News | Cryoport Inc : Stephens Cuts Target Price to $11 From $12